Barclays initiated coverage of Health Catalyst with an Overweight rating and $14 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCAT:
